| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.45 | 0.07 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.45 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.39 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |